CDC Morgellons study

The Stain That Would Settle It

by
Reactive perforating collagenosis and Morgellons comparison showing a mapped RPC tissue route beside an unmapped Morgellons route

Research criticism · Dermatopathology · Morgellons

Reactive Perforating Collagenosis and Morgellons share plug and collagen observations but diverge on anatomy and symptoms. An intact, elastic-stained lesion could distinguish their tissue routes.

Acquired perforating dermatosis Morgellons fibers Tissue architecture

In reactive perforating collagenosis, damaged collagen can be pushed out through skin—and a pathologist can see that route under the microscope. Some Morgellons lesions are described as cratered or plug-centered. Middelveen has sectioned attached callus material and reported follicular casts and comedo-like masses. Those observations justify testing whether some lesions fit the RPC or acquired perforating dermatosis pattern. They do not already establish that diagnosis.

Read more

Can Morgellons Be Diagnosed as a Delusion? What a New Psychodermatology Review Gets Right—and Wrong

by
Microscope and skin-biopsy slide beside a magnified histology section and medical research papers.

Research criticism • Psychodermatology • Source audit

A 2026 review correctly challenges reflexive psychiatric dismissal. Its own infectious claims, however, do not survive the same citation-level scrutiny.

LookExamine sensations, lesions, and fibers before interpreting them.

AttributeDistinguish a coexisting condition from a demonstrated cause.

VerifyFollow treatment and etiology claims back to their sources.

A patient can have real skin lesions, real fibers, real crawling sensations—and still face an unresolved question about what caused them. That is why disease versus delusion is the wrong binary.

Read more

Morgellons Fibers After Twenty Years: Reading the New Middelveen–Stricker Review

by
Morgellons Fiber Review After Twenty Years — source analysis of the new 2026 Middelveen–Stricker review.

A new review finally puts two decades of unpublished fiber data into the citable record. What it puts on the record — and how the publicity around it departs from the paper itself — deserves a careful read.

On July 31, 2026, Archives of Clinical and Biomedical Research published “The Cellular Origin of Morgellons Disease Fibers: A Twenty Year Odyssey” (Middelveen, Fesler, Stricker; ACBR 10(4):224–236, DOI 10.26502/acbr.50170529). It is a narrative review — the authors retracing the fiber-analysis literature from the 2004 Charles E. Holman Foundation fiber study through their own 2020 work — and it arrives with a stated mission: to consolidate the case that Morgellons fibers are human in origin, composed of keratin and collagen, produced by keratinocytes and fibroblasts, and in some cases identifiable as unusually small human hairs.

Read more

Same Name, Different Patients: Why Morgellons Studies Keep Contradicting Each Other

by
Patient advocate examining a microscope slide beside Morgellons research papers, illustrating conflicting study definitions.

Morgellons studies appear to reach opposite conclusions. The CDC-supported investigation identified ordinary environmental material and no common infectious cause. Filament-focused papers described biological structures associated with skin tissue and reported evidence of Borrelia. Psychiatric literature frequently classifies Morgellons as delusional infestation. These findings may conflict partly because the studies did not consistently examine the same patients, specimens or definition of Morgellons disease.

Every Morgellons investigation begins by deciding who qualifies as a case. That decision determines which patients enter the study, which materials are analyzed and what the results can reasonably establish. A population defined by self-reported fibers is not necessarily equivalent to one selected for filaments considered embedded in or projecting from tissue. A psychiatric referral population is different again.

This does not mean that every interpretation is equally supported. It means the evidence must be judged within the boundaries of each study. Until researchers establish reproducible diagnostic criteria and independent laboratories examine comparable specimens, the name “Morgellons” will continue to describe several overlapping—and potentially unrelated—clinical presentations.

Read more